The largest community of pharma leaders

Schrödinger Bolsters Translational Science Expertise with Leadership Expansion

NEW YORK–(BUSINESS WIRE)–Schrödinger today announced an expansion of its drug discovery leadership team to strengthen its expertise in preclinical development and translational science as the company advances internal drug discovery programs powered by its physics-based molecular modeling platform. Duncan Hamish Wright, Ph.D., who has previously served in senior positions in clinical pharmacology, global clinical development, and business development, joins Schrödinger as Vice President, Tran

Recent Articles